“Acute pancreatitis”的搜索结果，显示 211-220 项，共有 10043 项

1. 神经科- 临床试验- 妙佑医疗国际

   ... Pancreatic SPORE, “Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. Gendler). Eligibility Criteria, keep current ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors. Rochester, Minn., Scottsdale/Phoenix, Ariz. The purpose of this ...

3. 神经科- 临床试验- 妙佑医疗国际

   ... Pancreatic SPORE, “Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. Gendler). Eligibility Criteria, keep current ...

4. 血管中心- 临床试验- 妙佑医疗国际

   The purpose of this study is to analyze the effectiveness and safety of an embolic protection device compared to a standard aortic cannula to reduce the ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... of cancer in patients with high-risk well-differentiated pancreatic neuroendocrine tumors. ... of mirvetuximab + carboplatin for a total of 7 intended cycles of ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... of Locally-advanced Unresectable and Metastatic Pancreatic Cancer Therapies. Jacksonville, Fla. The purpose of this study is to determine if LIF (Leukemia ...

7. 放射科- 临床试验- 妙佑医疗国际

   VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, and explore ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Potentially Resectable Pancreatic Cancer - No involvement of the celiac ... - For tumors of the body and tail of the pancreas, involvement of the ...

9. 血液科- 临床试验- 妙佑医疗国际

   ... Pancreatic SPORE, “Optimal Immunotargeting of MUC1 for Advanced Pancreatic Cancer” (Principal Investigator Dr. Gendler). Eligibility Criteria, keep current ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    A Study Of Intratumoral Injection Of ... acute lymphoblastic leukemia. Monoclonal ... pancreatic cyst, pancreas fluid and tissue from a resected pancreatic cyst.